Literature DB >> 28052604

OPTN/SRTR 2015 Annual Data Report: Liver.

W R Kim1,2, J R Lake1,3, J M Smith1,4, M A Skeans1, D P Schladt1, E B Edwards5,6, A M Harper5,6, J L Wainright5,6, J J Snyder1,7, A K Israni1,7,8, B L Kasiske1,8.   

Abstract

Several notable developments in adult liver transplantation in the US occurred in 2015. The year saw the largest number of liver transplants to date, leading to reductions in median waiting time, in waitlist mortality for all model for end-stage liver disease categories, and in the number of candidates on the waiting list at the end of the year. Numbers of additions to the waiting list and of liver transplants performed in patients with hepatitis C virus infection decreased for the first time in recent years. However, other diagnoses, such as non-alcoholic fatty liver disease and alcoholic cirrhosis, became more prevalent. Despite large numbers of severely ill patients undergoing liver transplant, graft survival rates continued to improve. The number of new active candidates added to the pediatric liver transplant waiting list in 2015 was 689, down from a peak of 826 in 2005. The number of prevalent pediatric candidates (on the list on December 31 of the given year) continued to decline, to 373 active and 195 inactive candidates. The number of pediatric liver transplants peaked at 613 in 2008 and was 580 in 2015. The number of living donor pediatric liver transplants increased to its highest level, 79, in 2015; most were from donors closely related to the recipients. Pediatric graft survival rates continued to improve. .

Entities:  

Keywords:  Liver transplant; model for end-stage liver disease; waiting list

Mesh:

Substances:

Year:  2017        PMID: 28052604     DOI: 10.1111/ajt.14126

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  78 in total

1.  Association of pretransplant and posttransplant program ratings with candidate mortality after listing.

Authors:  Andrew Wey; Sally K Gustafson; Nicholas Salkowski; Bertram L Kasiske; Melissa Skeans; Cory R Schaffhausen; Ajay K Israni; Jon J Snyder
Journal:  Am J Transplant       Date:  2018-08-21       Impact factor: 8.086

2.  Short- and Long-Term Outcomes After Live-Donor Transplantation with Hyper-Reduced Liver Grafts in Low-Weight Pediatric Recipients.

Authors:  Micaela Raices; Matias Eduardo Czerwonko; Victoria Ardiles; Gustavo Boldrini; Daniel D'Agostino; José Marcó Del Pont; Juan Pekolj; Juan Mattera; Claudio Brandi; Miguel Ciardullo; Eduardo de Santibañes; Martin de Santibañes
Journal:  J Gastrointest Surg       Date:  2019-03-18       Impact factor: 3.452

3.  Expansion of the Liver Donor Supply Through Greater Use of Split-Liver Transplantation: Identifying Optimal Recipients.

Authors:  Douglas B Mogul; Xun Luo; Jacqueline Garonzik-Wang; Mary G Bowring; Allan B Massie; Kathleen B Schwarz; Andrew M Cameron; John F P Bridges; Dorry L Segev
Journal:  Liver Transpl       Date:  2019-01       Impact factor: 5.799

4.  Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding.

Authors:  Andrew M Moon; Pamela K Green; Don C Rockey; Kristin Berry; George N Ioannou
Journal:  Aliment Pharmacol Ther       Date:  2019-11-27       Impact factor: 8.171

5.  Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy.

Authors:  Emily D Bethea; Sumeyye Samur; Fasiha Kanwal; Turgay Ayer; Chin Hur; Mark S Roberts; Norah Terrault; Raymond T Chung; Jagpreet Chhatwal
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-21       Impact factor: 11.382

6.  Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States.

Authors:  Allison Kwong; W Ray Kim; Ajitha Mannalithara; Nae-Yun Heo; Prowpanga Udompap; Donghee Kim
Journal:  Liver Transpl       Date:  2018-03-25       Impact factor: 5.799

7.  Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.

Authors:  Christine E Haugen; Alvin G Thomas; Jacqueline Garonzik-Wang; Allan B Massie; Dorry L Segev
Journal:  Transplantation       Date:  2018-09       Impact factor: 4.939

8.  Pulse Oximetry Is Insensitive for Detection of Hepatopulmonary Syndrome in Patients Evaluated for Liver Transplantation.

Authors:  Kimberly A Forde; Michael B Fallon; Michael J Krowka; Michael Sprys; David S Goldberg; Karen L Krok; Mamta Patel; Grace Lin; Jae K Oh; Carl D Mottram; Paul D Scanlon; Steven M Kawut
Journal:  Hepatology       Date:  2018-12-18       Impact factor: 17.425

9.  Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.

Authors:  Hiroyuki Kato; Sergio Duarte; Mary G Miller; Ronald W Busuttil; Ana J Coito
Journal:  Liver Transpl       Date:  2019-02       Impact factor: 5.799

10.  Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide.

Authors:  Neil D Shah; Meritxell Ventura-Cots; Juan G Abraldes; Mohamed Alboraie; Ahmad Alfadhli; Josepmaria Argemi; Ester Badia-Aranda; Enrique Arús-Soler; A Sidney Barritt; Fernando Bessone; Marina Biryukova; Flair J Carrilho; Marlen Castellanos Fernández; Zaily Dorta Guiridi; Mohamed El Kassas; Teo Eng-Kiong; Alberto Queiroz Farias; Jacob George; Wenfang Gui; Prem H Thurairajah; John Chen Hsiang; Azra Husić-Selimovic; Vasily Isakov; Mercy Karoney; Won Kim; Johannes Kluwe; Rakesh Kochhar; Narendra Dhaka; Pedro Marques Costa; Mariana A Nabeshima Pharm; Suzane K Ono; Daniela Reis; Agustina Rodil; Caridad Ruenes Domech; Federico Sáez-Royuela; Christoph Scheurich; Way Siow; Nadja Sivac-Burina; Edna Solange Dos Santos Traquino; Fatma Some; Sanjin Spreckic; Shiyun Tan; Julio Vorobioff; Andrew Wandera; Pengbo Wu; Mohamed Yacoub; Ling Yang; Yuanjie Yu; Nerma Zahiragic; Chaoqun Zhang; Helena Cortez-Pinto; Ramon Bataller
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-29       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.